Gritstone Oncology, Inc. (GRTS) (CIK 0001656634)
Source:SEC EDGAR database•Date:July 9, 2018•SIC:2836•CIK:2836
Fifth Amendment to License Agreement
Source:SEC EDGAR database•Date:March 9, 2023•SIC:2836•CIK:2836
Ikena Oncology, Inc. (IKNA) (CIK 0001835579)
Source:SEC EDGAR database•Date:March 14, 2023•SIC:2836•CIK:2836
Kura Oncology, Inc. (KURA) (CIK 0001422143)
Source:SEC EDGAR database•Date:February 23, 2023•SIC:2834•CIK:2834
CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Source:SEC EDGAR database•Date:March 9, 2023•SIC:2834•CIK:2834
Ablynx NV (CIK 0001617582)
Source:SEC EDGAR database•Date:September 13, 2017•SIC:2836•CIK:2836
Amendment No. 1 to Amended and Restated License Agreement (Amendment No. 1)
Source:SEC EDGAR database•Date:March 22, 2023•SIC:2834•CIK:2834
Alaunos Therapeutics, Inc. (TCRT) (CIK 0001107421)
Source:SEC EDGAR database•Date:May 10, 2023•SIC:2834•CIK:2834
Separation Date Release, together with the Agreement (and its exhibits), constitutes the entire agreement
Source:SEC EDGAR database•Date:May 10, 2023•SIC:2834•CIK:2834
EXCLUSIVE LICENSE AGREEMENT
Source:SEC EDGAR database•Date:November 17, 2017•SIC:2836•CIK:2836